Premier Biomedical, Inc., a research-based company, discovers and develops medical treatments for various health issues. It offers pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; and oil-based pump spray applicators. The company markets its products through its Website, painreliefmeds.com; and various distributors. It is also developing additional pain relief products, including creams, sprays, gel pens, and capsules; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, or traumatic brain injuries. The company has a collaborative agreement with the University of Texas to develop a series of research and development programs for its sequential-dialysis technology in the areas of Alzheimer's disease, traumatic brain injury, chronic pain syndrome, fibromyalgia, multiple sclerosis, amyotrophic lateral sclerosis, blood sepsis, cancer, heart attacks, and strokes. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Phone+1-814-7868849
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Premier Biomedical (OTCMKTS:BIEI) Frequently Asked Questions
What is Premier Biomedical's stock symbol?
Premier Biomedical trades on the OTCMKTS under the ticker symbol "BIEI."
Has Premier Biomedical been receiving favorable news coverage?
News articles about BIEI stock have trended extremely negative recently, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Premier Biomedical earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Premier Biomedical.
Who are some of Premier Biomedical's key competitors?
Some companies that are related to Premier Biomedical include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF).
What other stocks do shareholders of Premier Biomedical own?
Who are Premier Biomedical's key executives?
Premier Biomedical's management team includes the folowing people:
- Mr. William A. Hartman, Pres, CEO & Director (Age 77)
- Ms. Heidi H. Carl, CFO, Sec.,Treasurer & Director (Age 48)
- Dr. Mitchell S. Felder, Co-Founder, Chairman of Directors & Chairman of the Scientific Advisory Board (Age 65)
- Dr. Patricio F. Reyes, CTO, Member of Scientific Advisory Board & Director (Age 72)
- Mr. Carl Eller, Marketing & Planning Vice-Pres
How do I buy shares of Premier Biomedical?
Shares of BIEI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Premier Biomedical's stock price today?
One share of BIEI stock can currently be purchased for approximately $0.00.
What is Premier Biomedical's official website?
How can I contact Premier Biomedical?
Premier Biomedical's mailing address is PO Box 31374, EL PASO, TX 79931-0374, United States. The company can be reached via phone at +1-814-7868849.
MarketBeat Community Rating for Premier Biomedical (OTCMKTS BIEI)
MarketBeat's community ratings are surveys of what our community members think about Premier Biomedical and other stocks. Vote "Outperform" if you believe BIEI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIEI will underperform the S&P 500 over the long term. You may vote once every thirty days.
